https://orcid.org/0000-0002-1226-2425
References
- Farlow MR, Yee RD, Dlouhy SR, et al. Gerstmann-Sträussler-Scheinker diseaseI. Extending the clinical spectrum. Neurology. 1989;39(11):1446–1452. doi: 10.1212/wnl.39.11.1446
- Minikel EV, Vallabh SM, Lek M, et al. Quantifying prion disease penetrance using large population control cohorts. Sci Transl Med. 2016;8(322):322ra9. doi: 10.1126/scitranslmed.aad5169
- Mano KK, Matsukawa T, Mitsui J, et al. Atypical parkinsonism caused by Pro105Leu mutation of prion protein: a broad clinical spectrum. Neurol Genet. 2016;2(1):e48. doi: 10.1212/NXG.0000000000000048
- Shiraishi A, Mizusawa H, Yamada M. Early and persistent sensory-psychiatric symptoms in an inherited prion disease with a PrP P105L mutation. J Neurol. 2002;249(12):1740–1741. doi: 10.1007/s00415-002-0907-x
- Itoh Y, Yamada M, Hayakawa M, et al. A variant of Gerstmann-Sträussler-Scheinker disease carrying codon 105 mutation with codon 129 polymorphism of the prion protein gene: a clinicopathological study. J Neurol Sci. 1994;127(1):77–86. doi: 10.1016/0022-510x(94)90138-4
- Iwasaki Y, Kizawa M, Hori N, et al. A case of Gerstmann-Straussler-Scheinker syndrome with the P105L prion protein gene mutation presenting with ataxia and extrapyramidal signs without spastic paraparesis. Clin Neurol Neurosur. 2009;111(7):606–609. doi: 10.1016/j.clineuro.2009.03.008
- Tesar A, Matej R, Kukal J, et al. Clinical variability in P102L Gerstmann-Sträussler-Scheinker syndrome. Ann Neurol. 2019;86(5):643–652. doi: 10.1002/ana.25579
- Yoshimura M, Yuan JH, Higashi K, et al. Correlation between clinical and radiologic features of patients with Gerstmann-Sträussler-Scheinker syndrome (Pro102Leu). J Neurol Sci. 2018;391:15–21. doi: 10.1016/j.jns.2018.05.012
- Arata H, Takashima H, Hirano R, et al. Early clinical signs and imaging findings in Gerstmann-Sträussler-Scheinker syndrome (Pro102Leu). Neurology. 2006;66(11):1672–1678. doi: 10.1212/01.wnl.0000218211.85675.18